Parvin Mehdipour

1.5k total citations
73 papers, 1.0k citations indexed

About

Parvin Mehdipour is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Parvin Mehdipour has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 18 papers in Genetics and 13 papers in Oncology. Recurrent topics in Parvin Mehdipour's work include Epigenetics and DNA Methylation (12 papers), Telomeres, Telomerase, and Senescence (10 papers) and BRCA gene mutations in cancer (9 papers). Parvin Mehdipour is often cited by papers focused on Epigenetics and DNA Methylation (12 papers), Telomeres, Telomerase, and Senescence (10 papers) and BRCA gene mutations in cancer (9 papers). Parvin Mehdipour collaborates with scholars based in Iran, Germany and United Kingdom. Parvin Mehdipour's co-authors include Fatemeh Karami, Morteza Atri, Saeed Pirouzpanah, Majid Kheirollahi, Fatemeh Bahreini, Ali Reza Soltanian, Javad Mohammadi‐Asl, Mohammad Hossein Modarressi, Hassan Fazilaty and Behrooz Karimi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemosphere and BioMed Research International.

In The Last Decade

Parvin Mehdipour

66 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Parvin Mehdipour Iran 19 524 278 258 232 93 73 1.0k
S V Nicosia United States 14 690 1.3× 215 0.8× 295 1.1× 273 1.2× 47 0.5× 31 1.3k
Nina‐Naomi Kreis Germany 25 718 1.4× 112 0.4× 388 1.5× 213 0.9× 47 0.5× 41 1.4k
Shigeaki Kato Japan 6 704 1.3× 304 1.1× 392 1.5× 99 0.4× 32 0.3× 9 1.1k
Vladimír Divoký Czechia 22 678 1.3× 155 0.6× 113 0.4× 183 0.8× 68 0.7× 78 1.6k
Christo Venkov United States 11 564 1.1× 234 0.8× 229 0.9× 118 0.5× 30 0.3× 20 1.1k
George T. Tkalcevic United States 13 684 1.3× 387 1.4× 276 1.1× 177 0.8× 47 0.5× 14 1.3k
Reinhard Pregla Germany 18 471 0.9× 408 1.5× 76 0.3× 206 0.9× 70 0.8× 30 1.2k
Cynthia Morata‐Tarifa Spain 12 451 0.9× 96 0.3× 595 2.3× 364 1.6× 91 1.0× 15 1.1k
Jan Novotný Czechia 21 737 1.4× 257 0.9× 406 1.6× 508 2.2× 32 0.3× 61 1.4k
Hakan Çam United States 18 565 1.1× 132 0.5× 423 1.6× 235 1.0× 44 0.5× 28 1.1k

Countries citing papers authored by Parvin Mehdipour

Since Specialization
Citations

This map shows the geographic impact of Parvin Mehdipour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parvin Mehdipour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parvin Mehdipour more than expected).

Fields of papers citing papers by Parvin Mehdipour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parvin Mehdipour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parvin Mehdipour. The network helps show where Parvin Mehdipour may publish in the future.

Co-authorship network of co-authors of Parvin Mehdipour

This figure shows the co-authorship network connecting the top 25 collaborators of Parvin Mehdipour. A scholar is included among the top collaborators of Parvin Mehdipour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parvin Mehdipour. Parvin Mehdipour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehdipour, Parvin, et al.. (2021). Evolutionary model of brain tumor circulating cells: Cellular galaxy. World Journal of Clinical Oncology. 12(1). 13–30. 6 indexed citations
2.
Azarnezhad, Asaad, et al.. (2018). Detection of CCND1 , C-MYC , and FGFR1 amplification using modified SYBR Green qPCR and FISH in breast cancer. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(4). 759–767. 1 indexed citations
3.
Mehdipour, Parvin, et al.. (2018). ATM in breast and brain tumors: a comprehensive review. Cancer Biology and Medicine. 15(3). 210–210. 23 indexed citations
4.
Mehdipour, Parvin, Payam Dadvand, Mohammad Hassan Ehrampoush, et al.. (2018). Environmental and behavioral determinants affecting the association of airway macrophages carbon load with distance to major roads and traffic density. Chemosphere. 217. 680–685. 9 indexed citations
5.
Mehdipour, Parvin, et al.. (2017). Exploration of Involved Key Genes and Signaling Diversity in Brain Tumors. Cellular and Molecular Neurobiology. 38(2). 393–419. 16 indexed citations
6.
Pirouzpanah, Saeed, et al.. (2017). Hypermethylation pattern of ESR and PgR genes and lacking estrogen and progesterone receptors in human breast cancer tumors: ER/PR subtypes. Cancer Biomarkers. 21(3). 621–638. 8 indexed citations
7.
Karami, Fatemeh, et al.. (2014). Key Role of Promoter Methylation and Inactivation of MCPH1 Gene in Brain Tumors. Journal of Neurology Research. 4. 132–137. 1 indexed citations
8.
Karami, Fatemeh & Parvin Mehdipour. (2013). A Comprehensive Focus on Global Spectrum ofBRCA1andBRCA2Mutations in Breast Cancer. BioMed Research International. 2013. 1–21. 129 indexed citations
10.
Davarnia, Behzad, et al.. (2012). The Association between BRCA1 Expression and Breast Cancer Tumorogenesis. SHILAP Revista de lepidopterología.
11.
Tehranian, Najmeh, Houri Sepehri, Parvin Mehdipour, et al.. (2012). Combination effect of PectaSol and Doxorubicin on viability, cell cycle arrest and apoptosis in DU‐145 and LNCaP prostate cancer cell lines. Cell Biology International. 36(7). 601–610. 27 indexed citations
12.
Dianatpour, Mehdi, et al.. (2012). Expression of Testis Specific Genes TSGA10, TEX101 and ODF3 in Breast Cancer. Iranian Red Crescent Medical Journal. 14(11). 730–4. 53 indexed citations
13.
Sabour, Siamak, et al.. (2012). VALIDATION OF FOOD FREQUENCY QUESTIONNAIRE TO ASSESS FOLATE INTAKE STATUS IN BREAST CANCER PATIENTS. Razi Journal of Medical Sciences. 18(92). 31–41. 15 indexed citations
14.
Mehdipour, Parvin, et al.. (2009). Investigation of TEL/AML1 and BCR/ABL genes fusion in Acute lymphoblastic leukemia (ALL) Patients and Follow-up Study in 25 Bone Marrow Transplanted (BMT) Patients Using Interphase Fluorescence In Situ Hybridization (FISH).. Shiraz E-Medical Journal. 10(4). 173–185. 1 indexed citations
15.
Pirouzpanah, Saeed, et al.. (2009). The Association of Plasma Folate, Vitamin B12 and Homocysteine Levels on Hypermethylation Status of RARβ2 Gene in Primary Breast Carcinoma. SHILAP Revista de lepidopterología. 5(2). 19–27. 6 indexed citations
16.
Hashemian, Amir Hossein, Ebrahim Hajizadeh, Anoshirvan Kazemnejad, Morteza Atri, & Parvin Mehdipour. (2009). Penetrance of BRCA1/BRCA2 specific gene mutations in Iranian women with breast cancer.. PubMed. 30(1). 41–4. 9 indexed citations
17.
Saadat, Mohammad, et al.. (2003). Radiological study of Down's syndrome in Tehran and Shiraz. The Journal of Qazvin University of Medical Sciences. 7(3). 83–87. 2 indexed citations
18.
Mehdipour, Parvin, et al.. (1996). DOWN'S SYNDROME: CYTOGENETIC STUDIES IN 150 CASES IN TEHRAN. The Medical Journal of The Islamic Republic of Iran. 10(1). 47–52. 4 indexed citations
19.
Mehdipour, Parvin. (1992). CYTOGENETIC PRENATAL DIAGNOSIS ON 66 CHORIONIC VILLUS SAMPLES IN IRAN. SHILAP Revista de lepidopterología. 21. 51–60. 1 indexed citations
20.
Farhud, D.D., Parvin Mehdipour, Max P. Baur, & Edward L. Korn. (1987). COMPARATIVE STUDIES OF THE CHROMOSOMAL ARRANGEMENT IN THE C-METAPHASE BETWEEN NORMAL KARYOTYPE AND TRISOMY-21. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026